This work reports the identification of the first case of a K⌹C-2-producing Pseudomonas putida isolate (PP36) in Brazil. The PP36 isolate was resistant to all the antimicrobials tested except polymyxin B. In addition to the discovered bla KPC-2 gene, genetic analysis showed the presence of a class 1 integron containing the dhfrXVb gene and the new allele arr-6, which codes for resistance to rifampin. These elements were found in an IncFI 65-kb plasmid.
, and that it showed intermediate resistance to tigecycline according to U.S. Federal Drug Administration breakpoints for Enterobacteriaceae that define a MIC of Յ2 as susceptible. E. coli ATCC 25922 was used as the control. Due to the resistance to all beta-lactams tested, the isolate was screened for the presence of extended-spectrum beta-lactamases (ESBLs) and class A and B carbapenemases (Table 1) . PCR amplifications and plasmid analysis were carried out as previously described (10), followed by sequencing of the amplicon in both strands (ABI 3100 platform; Applied Biosystems) and BLASTn analysis (www.ncbi.nlm.nih .gov/Blast.cgi). PCR-based replicon typing and transposon typing were performed as described (3, 6) .
Afterwards, genetic analysis resulted in the detection of the bla KPC-2 gene. The detection of the intI1 gene by specific PCR showed the presence of a class 1 integron. Furthermore, its variable region of ca. 1.5 kb was submitted to DNA sequencing that revealed the presence of the dhfrXVb gene, encoding the dihydrofolate reductase involved in resistance to trimethoprim, and the new allele arr-6, encoding the rifampin ADP-ribosylating transferase involved in resistance to rifampin. This new allele differs from arr-2 by an A-to-G mutation at the position ϩ293 (Lys98Arg) and from arr-3 by a silent G-to-A mutation at the position ϩ411. The PP36 isolate displayed two distinct plasmids with sizes of ca. 65 kb and 147 kb ( Table 1) that were extracted and introduced into Escherichia coli DH5␣ (10). The transformed cells, designated TF36, that were selected on Mueller-Hinton agar containing 100 g/ml ampicillin showed the presence of only the 65-kb plasmid that carried the bla KPC-2 gene as attested by specific PCR. Recently, Andrade et al. (1) described the presence of the plasmid types IncFII, IncN, and IncL/M carrying bla KPC among Enterobacteriaceae species in Brazil. In the present work, we identified a 65-kb IncFI-type plasmid carrying bla KPC . Acquisition of this plasmid yielded resistance to aztreonam, cephalosporins, carbapenems, and combinations of beta-lactam/beta-lactamase inhibitors to the transformed cells (Table 1) . It was noteworthy that MICs for ceftriaxone and imipenem increased 64-and 134-fold, respectively, in the TF36 strain compared to those of the DH5␣ strain.
The analysis of the genetic environment of bla KPC by amplification of the region between ISKpn7 and the bla KPC gene revealed a 200-bp deletion upstream of the bla KPC gene. It indicates the presence of a Tn4401c isoform located in the 65-kb IncFI plasmid. Since KPC-producing K. pneumoniae isolates are frequent in the hospital of study, it is possible that P. putida acquired a bla KPCcontaining plasmid from these isolates. This report confirmed for the first time in Brazil the presence of a plasmid-based bla KPC-2 gene in a hospital isolate of P. putida. Moreover, a new allele for rifampin resistance was identified. Despite careful and conservative use of antibiotics and good control practices, the present work and the recent identifications of the bla KPC genes in distinct Gramnegative pathogens emphasize the quick spreading of this gene in long-term facilities, limiting therapeutic options for infected hospitalized patients.
Nucleotide sequence accession numbers. The sequences for the newly detected bla KPC-2 gene, dhfrXVb gene, and arr-6 allele have been deposited in GenBank under accession numbers JF922884, JF922882, and JF922883, respectively.
